Wave Life Sciences (NASDAQ:WVE) Earns Overweight Rating from Analysts at Wells Fargo & Company
Wells Fargo & Company started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $11.00 target price on the stock. WVE has been the topic of several other research reports. Royal Bank of Canada reaffirmed a […]
More Stories
DOJ Charges 28 Noncitizens in California With Election Crimes
By Tom Gantert The Justice Department announced on Oct. 19 that 28 noncitizens living in California face election-related criminal charges,...
Homebuilder Confidence Drops in October Amid Weak Demand, Rising Costs
By Bill Pan Confidence among U.S. homebuilders fell in October, as rising mortgage rates discouraged buyers while construction costs and...
Elon Musk Pledges to Give ‘Every Kid in America’ 1 SpaceX Share
By Andrew Moran Billionaire Elon Musk said he will give every child in the United States a stake in his...
Vance Says He’ll Wait Until After Midterms to Decide on Presidential Run
By Jack Phillips Vice President JD Vance said he will wait until after the upcoming November midterm elections before making...
Oil Retreats From 5-Month High as Markets Weigh Trump’s Russia Sanctions Waiver
By Tom Ozimek Oil prices fell on Oct. 19, with Brent retreating from a five-month high as investors weighed President...
The Babysitter 3: Renewal Status, Release Date, Cast Members & Plot
Nine years after Netflix’s debut, the horror-comedy film The Babysitter remains one of the biggest hits. What began as a...